1. Home
  2. SKYW vs EWTX Comparison

SKYW vs EWTX Comparison

Compare SKYW & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWest Inc.

SKYW

SkyWest Inc.

HOLD

Current Price

$96.88

Market Cap

3.5B

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$39.56

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYW
EWTX
Founded
1972
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.7B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
SKYW
EWTX
Price
$96.88
$39.56
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$123.67
$39.00
AVG Volume (30 Days)
437.5K
1.6M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
33.20
N/A
EPS
2.50
N/A
Revenue
$2,971,963,000.00
N/A
Revenue This Year
$8.35
N/A
Revenue Next Year
$3.55
N/A
P/E Ratio
$38.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$77.89
$12.31
52 Week High
$123.94
$43.93

Technical Indicators

Market Signals
Indicator
SKYW
EWTX
Relative Strength Index (RSI) 62.88 58.11
Support Level $95.31 $29.03
Resistance Level $101.95 $40.36
Average True Range (ATR) 2.91 2.55
MACD 0.54 0.21
Stochastic Oscillator 63.30 66.62

Price Performance

Historical Comparison
SKYW
EWTX

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: